Effect site concentrations of remifentanil maintaining cardiovascular homeostasis in response to surgical stimuli during bispectral index guided propofol anestesia in seriously obese patients
- PMID: 17095989
Effect site concentrations of remifentanil maintaining cardiovascular homeostasis in response to surgical stimuli during bispectral index guided propofol anestesia in seriously obese patients
Abstract
Aim: The aim of this prospective study was to determine the effect site concentrations of remifentanil maintaining cardiovascular homeostasis in response to surgical stimuli during bispectral index (BIS) guided propofol anesthesia in seriously obese patients.
Methods: Twenty-two patients, female/male 15/7, ASA physical status II - III, aged 29-69 years, body mass index (BMI) 54.5+/-12, undergoing major open bariatric surgery, were enrolled to receive a propofol-remifentanil total intravenous anesthesia. All patients were intubated by using a flexible fiberoptic bronchoscopic technique facilitated by a target controlled effect site concentration of remifentanil set at 2.5 ng/mL. After endotracheal intubation, anesthesia was started with a target controlled infusion of propofol initially set at 6 microg/mL, then adjusted to maintain a BIS value between 40 and 50. The mean effect site concentration of remifentanil was recorded at different intervals time during surgery: skin incision-opening of peritoneum (T1), bowel resection (T2), cholecystojejunal anastomosis (T3), ileojejunal anastomosis (T4), closing of peritoneum (T5).
Results: The mean plasma concentrations of propofol required to maintain a BIS value between 40 and 50 were 4+/-0.55, 3.8+/-0.64, 3.8+/- 0.63, 3.8+/-0.65 and 3.8+/-0.63 microg/mL at T1, T2, T3, T4 and T5 interval time, respectively. The mean values of remifentanil target effect site concentration were 5.2+/-1.3, 7.7+/-1.7, 9.1+/-1.8, 9.7+/- 2.2 and 9.9+/-2.5 ng/mL at T1, T2, T3, T4 and T5 interval time.
Conclusions: This study suggests that tolerance to remifentanil infusion is profound and develops very rapidly in morbidly obese patients submitted to open bariatric surgery during BIS guided propofol anesthesia. The administration of opiates during anesthesia based on target-controlled infusion should include corrections for the development of tolerance.
Similar articles
-
The effect-site concentration of remifentanil blunting cardiovascular responses to tracheal intubation and skin incision during bispectral index-guided propofol anesthesia.Anesth Analg. 2005 Jul;101(1):125-30, table of contents. doi: 10.1213/01.ANE.0000153012.35120.FE. Anesth Analg. 2005. PMID: 15976218 Clinical Trial.
-
Relationship between depth of anesthesia and effect-site concentration of propofol during induction with the target-controlled infusion technique in elderly patients.Chin Med J (Engl). 2009 Apr 20;122(8):935-40. Chin Med J (Engl). 2009. PMID: 19493418 Clinical Trial.
-
C50 for propofol-remifentanil target-controlled infusion and bispectral index at loss of consciousness and response to painful stimulus in Chinese patients: a multicenter clinical trial.Anesth Analg. 2009 Feb;108(2):478-83. doi: 10.1213/ane.0b013e31818f8a30. Anesth Analg. 2009. PMID: 19151275 Clinical Trial.
-
Practicalities of Total Intravenous Anesthesia and Target-controlled Infusion in Children.Anesthesiology. 2019 Jul;131(1):164-185. doi: 10.1097/ALN.0000000000002657. Anesthesiology. 2019. PMID: 30920966 Review.
-
Advances in pharmacokinetic modeling: target controlled infusions in the obese.Curr Opin Anaesthesiol. 2018 Aug;31(4):415-422. doi: 10.1097/ACO.0000000000000619. Curr Opin Anaesthesiol. 2018. PMID: 29794852 Review.
Cited by
-
[Target-controlled infusion (TCI) - a concept with a future?: state-of-the-art, treatment recommendations and a look into the future].Anaesthesist. 2008 Mar;57(3):223-30. doi: 10.1007/s00101-008-1329-7. Anaesthesist. 2008. PMID: 18322665 Review. German.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous